# Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

> **NCT00019331** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)**

## Conditions studied

- Colorectal Cancer
- Endometrial Cancer
- Head and Neck Cancer
- Liver Cancer
- Lung Cancer
- Melanoma (Skin)
- Pancreatic Cancer
- Testicular Germ Cell Tumor
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **BIOLOGICAL:** aldesleukin
- **BIOLOGICAL:** ras peptide cancer vaccine
- **BIOLOGICAL:** sargramostim
- **DRUG:** DetoxPC

## Key facts

- **NCT ID:** NCT00019331
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-10
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00019331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00019331, "Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00019331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*